Alcohol induced hepatic degeneration in a hepatitis C virus core protein transgenic mouse model

International Journal of Molecular Sciences

Volumn 15, Issue 3, 2014, Pages 4126-4141

  Noh, Dong Hyung ^a   Lee, Eun Joo ^a   Kim, Ah Young ^a   Lee, Eun Mi ^a   Min, Chang Woo ^a   Kang, Kyung Ku ^a   Lee, Myeong Mi ^a   Kim, Sang Hyeob ^a   Sung, Soo Eun ^a   Hwang, Meeyul ^a   Yu, Dae Yeul ^b   Jeong, Kyu Shik ^a  

^a Kyungpook National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Alcohol; HCV core protein; Hepatitis C virus; TG 99

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN; CORE PROTEIN; CYCLIN DEPENDENT KINASE; GLUTATHIONE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P21; PROTEIN P53; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; ALCOHOL; CDKN1A PROTEIN, MOUSE; CENTRAL DEPRESSANT AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYTOCHROME P450 2E1; CYTOKERATIN 18; CYTOKERATIN 8; NUCLEOCAPSID PROTEIN, HEPATITIS C VIRUS;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DEGENERATION; ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER NECROSIS; LYMPHOCYTIC INFILTRATION; MALLORY BODY; MICROPHOTOGRAPHY; MOUSE; NONHUMAN; PHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY SEQUENCE; ANIMAL; C57BL MOUSE; CBA MOUSE; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; GENETICS; HUMAN; LIVER; LIVER CELL; LIVER DISEASES; METABOLISM; MUTATION; NECROSIS; PATHOLOGY; SMOOTH MUSCLE; TOXICITY; TRANSGENIC MOUSE;

ACTINS; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOCHROME P-450 CYP2E1; ETHANOL; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-18; KERATIN-8; LIVER; LIVER DISEASES; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MUSCLE, SMOOTH; MUTATION; NECROSIS; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; VIRAL CORE PROTEINS;

EID: 84896468661     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms15034126     Document Type: Article

References (52)

1. Irshad, M.; Dhar, I. Hepatitis C virus core protein: An update on its molecular biology, cellular functions and clinical implications. Med. Princ. Pract. 2006, 15, 405-416.
2. Shimotohno, K. Hepatitis C virus and its pathogenesis. Semin. Cancer Biol. 2000, 10, 233-240.
3. Irshad, M.; Mankotia, D. S.; Irshad, K. An insight into the diagnosis and pathogenesis of hepatitis C virus infection. World J. Gastroenterol. 2013, 19, 7896-7909.
4. Moudgil, V.; Redhu, D.; Dhanda, S.; Singh, J. A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses. J. Environ. Pathol. Toxicol. Oncol. 2013, 32, 165-175.
5. Koike, K. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. J. Gastroenterol. Hepatol. 2007, 22, S108-S111.
6. Moriya, K.; Fujie, H.; Shintani, Y.; Yotsuyanagi, H.; Tsutsumi, T.; Ishibashi, K.; Matsuura, Y.; Kimura, S.; Miyamura, T.; Koike, K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 1998, 4, 1065-1067.
7. Dubourdeau, M.; Miyamura, T.; Matsuura, Y.; Alric, L.; Pipy, B.; Rousseau, D. Infection of HepG2 cells with recombinant adenovirus encoding the HCV core protein induces p21(WAF1) down-regulation-Effect of transforming growth factor beta. J. Hepatol. 2002, 37, 486-492.
8. Honda, A.; Hatano, M.; Kohara, M.; Arai, Y.; Hartatik, T.; Moriyama, T.; Imawari, M.; Koike, K.; Yokosuka, O.; Shimotohno, K.; et al. HCV-core protein accelerates recovery from the insensitivity of liver cells to fas-mediated apoptosis induced by an injection of anti-fas antibody in mice. J. Hepatol. 2000, 33, 440-447.
9. Morgan, T. R.; Brenner, D.; Everhart, J.; French, S. W.; Fried, M. W.; Gretch, D. R.; Koziel, M. J.; McClain, C. J.; Peters, M. G.; Weinman, S. A.; et al. Hepatitis C and alcohol: Fundamental and translational research directions. Alcohol. Clin. Exp. Res. 2003, 27, 726-731.
10. Cardin, R.; D'Errico, A.; Fiorentino, M.; Cecchetto, A.; Naccarato, R.; Farinati, F. Hepatocyte proliferation and apoptosis in relation to oxidative damage in alcohol-related liver disease. Alcohol Alcohol. 2002, 37, 43-48.
11. Niemela, O. Distribution of ethanol-induced protein adducts in vivo: Relationship to tissue injury. Free Radic. Biol. Med. 2001, 31, 1533-1538.
12. Comporti, M.; Signorini, C.; Leoncini, S.; Gardi, C.; Ciccoli, L.; Giardini, A.; Vecchio, D.; Arezzini, B. Ethanol-induced oxidative stress: Basic knowledge. Genes Nutr. 2010, 5, 101-109.
13. Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 2007, 121, 2381-2386.
14. Gitto, S.; Micco, L.; Conti, F.; Andreone, P.; Bernardi, M. Alcohol and viral hepatitis: A mini-review. Dig. Liver Dis. 2009, 41, 67-70.
15. Cooksley, W. Chronic liver disease: Do alcohol and hepatitis C virus. Interact. J. Gastroenterol. Hepatol. 1996, 11, 187-192.
16. Moriya, K.; Nakagawa, K.; Santa, T.; Shintani, Y.; Fujie, H.; Miyoshi, H.; Tsutsumi, T.; Miyazawa, T.; Ishibashi, K.; Horie, T.; et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res. 2001, 61, 4365-4370.
17. Donato, F.; Tagger, A.; Chiesa, R.; Ribero, M. L.; Tomasoni, V.; Fasola, M.; Gelatti, U.; Portera, G.; Boffetta, P.; Nardi, G. Hepatitis B and C virus infection, alcohol drinking, and hepatocellular carcinoma: A case-control study in Italy. Brescia HCC study. Hepatology 1997, 26, 579-584.
18. Mercer, D. F. Animal models for studying hepatitis C and alcohol effects on liver. World J. Gastroenterol. 2011, 17, 2515-2519.
19. Wang, A. G.; Moon, H. B.; Lee, Y. H.; Yu, S. L.; Kwon, H. J.; Han, Y. H.; Fang, W.; Lee, T. H.; Jang, K. L.; Kim, S. K.; et al. Transgenic expression of Korean type hepatitis C virus core protein and related mutants in mice. Exp. Mol. Med. 2004, 36, 588-593.
20. Shih, C. M.; Chen, C. M.; Chen, S. Y.; Lee, Y. H. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 1995, 69, 1160-1171.
21. Ekstrom, G.; Ingelman-Sundberg, M. Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem. Pharmacol. 1989, 38, 1313-1319.
22. Zatloukal, K.; Stumptner, C.; Lehner, M.; Denk, H.; Baribault, H.; Eshkind, L. G.; Franke, W. W. Cytokeratin 8 protects from hepatotoxicity, and its ratio to cytokeratin 18 determines the ability of hepatocytes to form mallory bodies. Am. J. Pathol. 2000, 156, 1263-1274.
23. Shen, H.; Huang, G.; Hadi, M.; Choy, P.; Zhang, M.; Minuk, G. Y.; Chen, Y.; Gong, Y. Transforming growth factor-beta1 downregulation of smad1 gene expression in rat hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 285, G539-G546.
24. Matsuzaki, K. Modulation of TGF-beta signaling during progression of chronic liver diseases. Front. Biosci. (Landmark Ed.) 2009, 14, 2923-2934.
25. Kessova, I.; Cederbaum, A. I. CYP2E1: Biochemistry, toxicology, regulation and function in ethanol-induced liver injury. Curr. Mol. Med. 2003, 3, 509-518.
26. Lai, M. M. Hepatitis C virus proteins: Direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. Gastroenterology 2002, 122, 568-571.
27. Okuda, M.; Li, K.; Beard, M. R.; Showalter, L. A.; Scholle, F.; Lemon, S. M.; Weinman, S. A. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002, 122, 366-375.
28. De la M Hall, P.; Lieber, C. S.; DeCarli, L. M.; French, S. W.; Lindros, K. O.; Jarvelainen, H.; Bode, C.; Parlesak, A.; Bode, J. C. Models of alcoholic liver disease in rodents: A critical evaluation. Alcohol. Clin. Exp. Res. 2001, 25, 254S-261S.
29. Jensen, K.; Gluud, C. The mallory body: Morphological, clinical and experimental studies (part 1 of a literature survey). Hepatology 1994, 20, 1061-1077.
30. Jensen, K.; Gluud, C. The mallory body: Theories on development and pathological significance (part 2 of a literature survey). Hepatology 1994, 20, 1330-1342.
31. Wang, M. X.; Morgan, T.; Lungo, W.; Wang, L.; Sze, G. Z.; French, S. W. "Piecemeal" necrosis: Renamed troxis necrosis. Exp. Mol. Pathol. 2001, 71, 137-146.
32. Matsuzaki, K.; Seki, T.; Okazaki, K. TGF-beta signal shifting between tumor suppression and fibro-carcinogenesis in human chronic liver diseases. J. Gastroenterol. 2013, doi: 10. 1007/s00535-013-0910-2.
33. Wagayama, H.; Shiraki, K.; Sugimoto, K.; Ito, T.; Fujikawa, K.; Yamanaka, T.; Takase, K.; Nakano, T. High expression of p21WAF1/CIP1 is correlated with human hepatocellular carcinoma in patients with hepatitis C virus-associated chronic liver diseases. Hum. Pathol. 2002, 33, 429-434.
34. Elbendary, A. A.; Cirisano, F. D.; Evans, A. C., Jr.; Davis, P. L.; Iglehart, J. D.; Marks, J. R.; Berchuck, A. Relationship between p21 expression and mutation of the p53 tumor suppressor gene in normal and malignant ovarian epithelial cells. Clin. Cancer Res. 1996, 2, 1571-1575.
35. Suzuki, A.; Tsutomi, Y.; Akahane, K.; Araki, T.; Miura, M. Resistance to fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene 1998, 17, 931-939.
36. Pines, J. Cell cycle. p21 inhibits cyclin shock. Nature 1994, 369, 520-521.
37. Datto, M. B.; Li, Y.; Panus, J. F.; Howe, D. J.; Xiong, Y.; Wang, X. F. Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc. Natl. Acad. Sci. USA 1995, 92, 5545-5549.
38. Russo, T.; Zambrano, N.; Esposito, F.; Ammendola, R.; Cimino, F.; Fiscella, M.; Jackman, J.; O'Connor, P. M.; Anderson, C. W.; Appella, E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 1995, 270, 29386-29391.
39. Qiu, X.; Forman, H. J.; Schonthal, A. H.; Cadenas, E. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells. J. Biol. Chem. 1996, 271, 31915-31921.
40. Marx, J. Cell biology. Cell cycle inhibitors may help brake growth as cells develop. Science 1995, 267, 963-964.
41. Gorospe, M.; Shack, S.; Guyton, K. Z.; Samid, D.; Holbrook, N. J. Up-regulation and functional role of p21Waf1/Cip1 during growth arrest of human breast carcinoma MCF-7 cells by phenylacetate. Cell Growth Differ. 1996, 7, 1609-1615.
42. Guo, W.; Baluda, M. A.; Park, N. H. Ethanol upregulates the expression of p21 WAF1/CIP1 and prolongs G1 transition via a p53-independent pathway in human epithelial cells. Oncogene 1997, 15, 1143-1149.
43. Kobayashi, S.; Matsushita, K.; Saigo, K.; Urashima, T.; Asano, T.; Hayashi, H.; Ochiai, T. P21WAF1/CIP1 messenger RNA expression in hepatitis B, C virus-infected human hepatocellular carcinoma tissues. Cancer 2001, 91, 2096-2103.
44. Ozcelik, H.; Mousses, S.; Andrulis, I. L. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations. Clin. Cancer Res. 1995, 1, 907-912.
45. Kondo, T.; Suda, T.; Fukuyama, H.; Adachi, M.; Nagata, S. Essential roles of the fas ligand in the development of hepatitis. Nat. Med. 1997, 3, 409-413.
46. Qin, L. F.; Ng, I. O. Expression of p27(KIP1) and p21(WAF1/CIP1) in primary hepatocellular carcinoma: Clinicopathologic correlation and survival analysis. Hum. Pathol. 2001, 32, 778-784.
47. Yamanaka, T.; Kodama, T.; Doi, T. Subcellular localization of HCV core protein regulates its ability for p53 activation and p21 suppression. Biochem. Biophys. Res. Commun. 2002, 294, 528-534.
48. Yamanaka, T.; Uchida, M.; Doi, T. Innate form of HCV core protein plays an important role in the localization and the function of HCV core protein. Biochem. Biophys. Res. Commun. 2002, 294, 521-527.
49. Matsuzaki, K. Smad phosphoisoform signals in acute and chronic liver injury: Similarities and differences between epithelial and mesenchymal cells. Cell Tissue Res. 2012, 347, 225-243.
50. Hayashi, H.; Sakai, T. Animal models for the study of liver fibrosis: New insights from knockout mouse models. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300, G729-G738.
51. Brandon-Warner, E.; Schrum, L. W.; Schmidt, C. M.; McKillop, I. H. Rodent models of alcoholic liver disease: Of mice and men. Alcohol 2012, 46, 715-725.
52. Arteel, G. E. Animal models of alcoholic liver disease. Dig. Dis. 2010, 28, 729-736.